1,2-dipalmitoylphosphatidylcholine has been researched along with Arteriosclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernar, H; Brouwers, E; Collen, D; Holvoet, P; Perez, G; Rosseneu, M; Vanloo, B | 1 |
Bisgaier, CL; Cercek, B; Chyu, KY; Drake, S; Kaul, S; Reyes, O; Shah, PK; Yano, J | 1 |
2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Arteriosclerosis
Article | Year |
---|---|
Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antibodies, Monoclonal; Apolipoprotein A-I; Arteriosclerosis; Biological Transport; Carotid Artery Diseases; Cell Line; Cholesterol Esters; Endarterectomy, Carotid; Foam Cells; Humans; Kinetics; Lipoproteins, LDL; Macrophages; Membrane Proteins; Mice; Mice, Inbred BALB C; Protein Binding; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; Structure-Activity Relationship | 1994 |
High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Apolipoprotein A-I; Apolipoproteins E; Arteriosclerosis; Cholesterol; Dose-Response Relationship, Drug; Lipid Metabolism; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Recombinant Proteins; Sinus of Valsalva | 2001 |